Markets

Just two years after Apple became the first publicly listed U.S. company with a US$1 trillion stock market value, the iPhone maker has now topped US$2 trillion.

U.S. President Donald Trump on Wednesday called for a boycott of Goodyear Tire & Rubber Co following a local news report in Kansas that the company has deemed political attire including that of the Trump campaign unacceptable for the workplace.

Departing World Trade Organization Director General Roberto Azevedo will join PepsiCo Inc as chief corporate affairs officer, the soft drink and snack foods giant said on Wednesday as the WTO remains far from deciding on a successor.

U.S. President Donald Trump on Wednesday called for a boycott of Goodyear Tire & Rubber Co , saying they had banned his red presidential campaign hats.

Apple Inc became the first publicly listed U.S. company with a US$2 trillion stock market value on Wednesday, as Wall Street investors put aside challenges to its iPhone ecosystem in favor of bets it will only prosper more in the post-coronavirus world.

The United States on Wednesday imposed sanctions on two UAE-based companies, accusing them of providing support to U.S.-blacklisted Mahan Air.

HONG KONG: Hong Kong Exchanges and Clearing (HKEX) sees a trend of secondary listings by New York-listed Chinese companies bolstering its prospects, as the bourse reported a 1 per cent increase in first-half profit on Wednesday (Aug 19). E-commerce giant Alibaba completed its secondary listing in ...

SINGAPORE: Grain trader Archer Daniels Midland Co (ADM) said on Wednesday (Aug 19) it plans to sell shares and bonds in Singapore-based Wilmar International with a combined value of US$800 million. ADM, which is one of Wilmar's largest shareholders, added that it expects to retain at least a 20...

Citigroup Inc is suing two more lenders, HPS Investment Partners and Symphony Asset Management, for allegedly refusing to return a combined US$237 million that was mistakenly sent out by the bank, court documents showed.

Shares of Gilead Sciences fell 3per cent after the U.S. Food and Drug Administration declined to approve its experimental rheumatoid arthritis treatment, a major setback for one of the drugmaker's important products.